Dr. Reddy’s Generic Ozempic Supplies Delayed on API Issue
· Financial Post
(Bloomberg) — Dr. Reddy’s Laboratories Ltd. will delay the commercial production of its generic Ozempic drug after it found an unspecified issue with the active pharmaceutical ingredient in some batches of the anti-obesity and diabetes therapy. Read More
Visit umafrika.club for more information.